학술논문
Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15560864